Page 233 - FBL AR 2019-20
P. 233

CORPORATE   STATUTORY  FINANCIAL
                                                                                        OVERVIEW  STATEMENTS  STATEMENTS



            Notes to the Consolidated financial statements for the year ended March 31, 2020

            60  Share-based payments (contd.)

            Each employee share option converts into one equity share of the Parent Company on exercise. No amounts are paid or payable by the
            recipient on receipt of the option. The options carry neither rights to dividends nor voting rights. Options may be exercised at any time from
            the date of vesting to the date of their expiry.
            The number of options granted is calculated in accordance with the performance-based formula and is subject to approval by the
            remuneration committee. The formula rewards executives and senior employees to the extent of the Parent Company and the individual’s
            achievement judged against both qualitative and quantitative criteria.
            The following share-based payment arrangements were in existence during the current year:
                                                                                                       ( H in Lakhs )
            Options series                          Number**    Grant date   Expiry date  Exercise price  Fair value at
                                                                                                      grant date
            Plan 1 (60% of options granted under ESOP 2019)  1,26,143  25.02.2019 and   25.02.2025 and   83.67   421.71
                                                                12.08.2019   12.08.2025
            Plan 1 (20% of options granted under ESOP 2019)  42,047  25.02.2019 and   25.02.2026 and   83.67   421.71
                                                                12.08.2019   12.08.2026
            Plan 1 (20% of options granted under ESOP 2019)  42,047  25.02.2019 and   25.02.2027 and   83.67   421.71
                                                                12.08.2019   12.08.2027
            Plan 2 (100% of options granted under ESOP 2019)  2,17,410  25.02.2019   25.02.2025   83.67   418.22
            Options granted under ESOP 2019 shall vest not before 1 (one) year and not later than maximum Vesting Period of 5 (five) years from the date
            of grant of such Options. Subject to the minimum vesting period of one year, the Nomination and Remuneration Committee of the Board at
            its discretion approve for acceleration of Vesting of any or all unvested Options of the Option Grantee.

            The above number of options, fair value at grant dates and exercise price are adjusted in accordance with the Share exchange ratio (0.398:1)
            as per the scheme of amalgamation.
            **The number of options are after giving effect of the scheme of amalgamation and bonus shares issued during the year.
            1.2   Fair value of share options granted
            The weighted average fair value of the share options granted during the financial year is  H421.71 (Previous year H419.86). Options were priced
            using Black-Scholes option pricing model. Where relevant, the expected life used in the model has been calculated based on a weighted
            average of vests. Expected volatility is based on the historical share price information of similar listed entities.
                                                                                                       ( H in Lakhs )
            Inputs into the model                               Option series - Year -2020**
                                      Plan 1 (60% of options  Plan 1 (20% of options  Plan 1 (20% of options   Plan 2 (100% of
                                      granted under ESOP   granted under ESOP   granted under ESOP   options granted under
                                            2019)              2019)             2019)            ESOP 2019)
            Grant date share price                421.71             421.71             421.71            418.22
            Exercise price                         83.67              83.67             83.67              83.67
            Expected volatility                   69.28%            68.83%             68.08%             69.28%
            Option life                         4.51 years         5.51 years        6.51 years         4.51 years
            Dividend yield                         0.00%             0.00%              0.00%              0.00%
            Risk-free interest rate                7.14%             7.25%              7.35%              7.14%
            **The above fair value at grant dates and exercise price are adjusted in accordance with the Share exchange ratio (0.398:1) as per the scheme
            of amalgamation.
















                                                                                                             231
   228   229   230   231   232   233   234   235   236   237   238